Scope, originality and approval

• The manuscript has a direct and clearly explained pharmaceutical or pharmacy contribution.
• The work is original, has not been published in the same form and is not being considered by another journal.
• All authors have approved the submitted version, author order, affiliations and corresponding author.
• Related manuscripts, preprints, conference abstracts, protocols and datasets have been disclosed to the editor.

Manuscript and files

• The editable manuscript follows the appropriate article structure and is written in clear, consistent English.
• Title, abstract, keywords, names, affiliations and funding information match the OJS metadata.
• Pages are numbered; abbreviations are defined; SI units and generic medicine names are used appropriately.
• Every table and figure is cited in order, has a complete title or legend and does not duplicate the text.
• Images are original or accompanied by documented permission, and any processing or assembly is transparent.
• Supplementary files are named, cited and described clearly.

Methods and reporting

• The methods identify the study design, materials, setting, dates, sample-size basis, controls, procedures, outcomes and statistics in reproducible detail.
• The relevant reporting guideline and checklist have been used and uploaded where appropriate.
• Results include suitable denominators, units, effect estimates and uncertainty and are consistent across text, tables, figures and supplementary files.
• Limitations and the boundaries of the conclusions are stated honestly.

Ethics and transparency

• Ethics committee or institutional review information, approval number and consent process are reported where required.
• Clinical-trial registration details are provided when applicable.
• Animal studies report approval and follow applicable welfare and ARRIVE expectations.
• Author contributions, acknowledgements, funding and all relevant competing interests are declared.
• A data-availability statement explains where supporting data can be found or why access is restricted.
• Any generative-AI or AI-assisted tool use is disclosed as required; no AI system is named as an author.
• All references have been checked against the source, follow Vancouver style and do not include fabricated or retracted evidence as valid support.

Submission and communication

• The complete submission is being made through OJS rather than sent as an email attachment.
• The corresponding author's current email address is monitored and can receive journal messages.
• No payment has been offered or made to influence review, and the authors understand that the publication charge applies only after acceptance.